Rheumatology Patient Registry and Biorepository

  • STATUS
    Recruiting
  • End date
    Jun 1, 2040
  • participants needed
    5000
  • sponsor
    Yale University
Updated on 14 October 2021
myositis
connective tissue disease
sjogren's syndrome
autoimmune disease
vasculitis
arthritis
rheumatic diseases
rheumatism
prednisolone acetate ophthalmic suspension
sarcoidosis
lupus
polymyalgia rheumatica
reactive arthritis
scleroderma
rheumatoid arthritis
dermatomyositis
spondylitis
giant cell arteritis
arteritis
adult onset still's disease
polymyositis
mixed connective tissue disease
ankylosing spondylitis
polymyalgia
antiphospholipid syndrome
Accepts healthy volunteers

Summary

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Description

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients seen at Yale clinics diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease.

Details
Condition Connective Tissue Diseases, Psoriasis, Sjogren's Syndrome, Arthritis and Arthritic Pain (Pediatric), Behçet Disease, Xerostomia, sarcoid, Psoriatic Arthritis, behcet's disease, Arthritis and Arthritic Pain, Congenital Skin Diseases, Musculoskeletal Disease, Polymyositis (Inflammatory Muscle Disease), progressive systemic sclerosis, Adult Onset Still's Disease, Polymyalgia Rheumatica (PMR), Polymyalgia Rheumatica, SYSTEMIC LUPUS ERYTHEMATOSUS, Reiter's Syndrome, Dry Mouth, Autoimmune Disease, Sarcoidosis, Reiter's syndrome, Lymphoproliferative Disorder, Rheumatism, Lyme Disease Vaccine, Autoimmune disease, Giant Cell Arteritis, Dermatomyositis (Connective Tissue Disease), Mixed Connective Tissue Disease, Anterior uveitis, Systemic Lupus Erythematosus, Ankylosing spondylitis, rheumatic, Ankylosing Spondylitis, Idiopathic Inflammatory Myopathies, reactive arthritis, Rheumatoid Arthritis (Pediatric), rheumatic diseases, Skin Conditions, Antiphospholipid Syndrome, Dermatomyositis, Myositis, Rheumatoid Arthritis, Psoriasis and Psoriatic Disorders, temporal arteritis, CONNECTIVE TISSUE DISEASE, Arthritis, Lyme Disease, Lymphoproliferative disorders, PSORIATIC ARTHRITIS, Polymyositis, Behcet's Syndrome, Anterior Uveitis, Dermatosis, Systemic sclerosis, Sicca Syndrome, Scleroderma, Musculoskeletal Diseases
Clinical Study IdentifierNCT04402086
SponsorYale University
Last Modified on14 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Age 18 years old
No chronic skin conditions
No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis)
Normal BMI

Exclusion Criteria

Unable to provide informed consent
Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman
Allergies to lidocaine or epinephrine (skin biopsies)
A history of impaired wound healing (skin biopsies)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note